TrialBritish journal of clinical pharmacology2019

Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy.

Christina Brock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.